Mirabegron
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Mirabegron and local guidelines before prescribing.
Beta-3 agonist
Mechanism
Beta-3 agonist relaxing the detrusor.
Uses
Overactive bladder (alternative to antimuscarinics).
Dosing
- Medicines : Drug Use Side effects Alpha-blocker (tamsulosin, alfuzosin) First-line for moderate to severe voiding symptoms; works in days Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery) 5-alpha reductase inhibitor (finasteride, dutasteride) Enlarged prostate …
Surgey: Urology - LUTS (NICE CG97): frequency, nocturia, hesitancy, poor stream; examine abdomen and prostate, urinalysis, U&E, PSA after counselling; frequency–volume chart. Treatment: lifestyle, alpha-blocker (tamsulosin) for moderate–severe voiding symptoms, 5-alpha reductase inhibitor (finasteride) if prostate is estimated >30 g or PSA >1.4; …
General Practice: Child health, women's health and men's health in primary care
Side effects
Hypertension, tachycardia, UTI, headache.
Interactions
CYP2D6 inhibitor raising metoprolol and digoxin levels.
Contraindications and cautions
Severe uncontrolled hypertension
Monitoring
BP
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in severe renal or hepatic impairment
Overdose and reversal
Supportive
Special advice
Check BP before and during treatment; avoids anticholinergic cognitive burden.
More from the textbook: uses, cautions and other points
- Urgency - antimuscarinics (beware cognitive side effects; trospium is less likely to cause them) or mirabegron.
Neurology: Multiple Sclerosis and inflammatory disease - Mirabegron (beta-3 agonist) - no anticholinergic burden; can raise blood pressure (avoid in severe uncontrolled hypertension; monitor).
Renal: Anatomy, Physiology and Pharmacology - Mirabegron (beta-3 agonist) - if antimuscarinics are contraindicated, not tolerated, or not effective; or preferred in older people. Check BP (avoid in severe uncontrolled hypertension). Vibegron is another option.
Gynaecology: Pelvic floor ovary and vulva - Mirabegron | Beta-3 agonist for OAB; check BP; avoid in severe uncontrolled hypertension.
Gynaecology: Pelvic floor ovary and vulva - Avoid oxybutynin; consider mirabegron (check BP) rather than antimuscarinics.
Gynaecology: Pelvic floor ovary and vulva - Overactive bladder: reduce caffeine, bladder training 6 weeks, then antimuscarinics or mirabegron; avoid oxybutynin in frail older women.
Gynaecology: Pelvic floor ovary and vulva - Symptom treatments - spasticity (baclofen, gabapentin, tizanidine, botulinum toxin, physiotherapy); bladder (antimuscarinics or mirabegron, intermittent self-catheterisation if residual volume is high); fatigue (exercise, amantadine - NICE recommends against modafinil and others routinely); neuropathic pain ; fampridine (walking speed - …
Neurology: Anatomy, Physiology and Pharmacology - Then treat urgency (antimuscarinic or mirabegron); continence or urology referral.
Neurology: Multiple Sclerosis and inflammatory disease
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (2 mentions)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Gynaecology: Pelvic floor ovary and vulva (4 mentions)
- Surgey: Urology (5 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (4 mentions)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (2 mentions)
- General Practice: Child health, women's health and men's health in primary care (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)